MedTrace Logo

Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease

NCT00462657 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2013-08-26

No results posted yet for this study

Summary

RATIONALE: Studying ways to diagnose fungal infections early may help doctors plan the best treatment.

PURPOSE: This clinical trial is studying laboratory tests to see how well they find aspergillosis early in patients at high risk of fungal infection caused by treatment for hematologic cancer or other disease.

Conditions

Interventions

GENETIC

polymerase chain reaction

OTHER

bronchoalveolar lavage

OTHER

immunoenzyme technique

OTHER

laboratory biomarker analysis

PROCEDURE

bronchoscopy

PROCEDURE

management of therapy complications

Sponsors & Collaborators

  • St. Bartholomew's Hospital

    lead OTHER

Principal Investigators

  • Samir G Agrawal, MD, PhD · St. Bartholomew's Hospital

Study Design

Purpose
DIAGNOSTIC

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00462657 on ClinicalTrials.gov